SEC 13F Intelligence

Gates Foundation / VIR

Gates Foundation’s Vir Biotechnology Inc Position

Does Gates Foundation own Vir Biotechnology Inc (VIR)? Yes — 1.56M shares worth $12M (+26.84% of its 13F portfolio) as of Q3 2024.

Position Value
$12M
Q3 2024
Shares
1.56M
% of Portfolio
+26.84%
Quarters Held
16
currently held

Position History VIR

Reported value by quarter
Q4 ’20: $74MQ4 ’20Q1 ’21: $142MQ2 ’21: $131MQ2 ’21Q3 ’21: $30MQ4 ’21: $28MQ4 ’21Q1 ’22: $40MQ2 ’22: $40MQ2 ’22Q3 ’22: $30MQ4 ’22: $39MQ4 ’22Q1 ’23: $36MQ2 ’23: $38MQ2 ’23Q3 ’23: $15MQ4 ’23: $16MQ4 ’23Q1 ’24: $16MQ2 ’24: $14MQ2 ’24Q3 ’24: $12Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q3 20241.56M$12M+26.84%
Q2 20241.56M$14M+23.22%
Q1 20241.56M$16M+18.77%
Q4 20231.56M$16M+17.45%
Q3 20231.56M$15M+17.42%
Q2 20231.56M$38M+30.44%
Q1 20231.56M$36M+32.04%
Q4 20221.56M$39M+30.41%
Q3 20221.56M$30M+23.79%
Q2 20221.56M$40M+30.51%
Q1 20221.56M$40M+21.56%
Q4 2021677.8K$28M+8.62%
Q3 2021677.8K$30M+8.64%
Q2 20212.78M$131M+18.94%
Q1 20212.78M$142M+21.71%
Q4 20202.78M$74M+16.90%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Gates Foundation’s full portfolio or all institutional holders of VIR.